Please Wait

Applying Filters...

Bacitracin
NDC API
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Bacitracin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 22 USDMF, 5 CEP/COS, 2 JDMF, 17 NDC API, 1 VMF, 13 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers, 39 FDA Orange Book, 4 Europe, 16 Canada, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 2 DKSH, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 10 Actylis, 11 BASF, 1 Finar, 5 Gangwal Chemicals, 4 Kerry, 2 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Pluviaendo, 5 Roquette, 7 Seppic

EXCIPIENTS BY APPLICATIONS

19 Topical, 15 Solubilizers, 13 Parenteral, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 8 Film Formers & Plasticizers, 6 Emulsifying Agents, 5 Direct Compression, 5 Co-Processed Excipients, 4 Surfactant & Foaming Agents, 4 Fillers, Diluents & Binders, 3 Granulation, 3 Lubricants & Glidants, 2 Taste Masking, 2 Controlled & Modified Release, 2 Rheology Modifiers, 1 API Stability Enhancers

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 Regulatory FDF Prices

5 Regulatory FDF Prices

MARKET PLACE

22 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 1 Others

$ Xls download

Filters

Log in to access your PharmaMiles and download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Labeler	NDC Package Code	Non Proprietary Name	Start Marketing Date	End Marketing Date	Category Code	Dosage Form (Strength)
28/03/2025	Fagron Group	Netherlands	Fagron Services BV	76003-0162	Bacitracin	2010-09-01	2025-12-31	BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING	POWDER (1g/g)
28/03/2025	Josun International	China	Josun International Limited	51551-0302	Bacitracin Zinc	2017-02-04	2025-12-31	BULK INGREDIENT	POWDER (1kg/kg)

Contact us
to update this info

Bacitracin

Bacitracin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

35 API Suppliers

22 USDMF

5 CEP/COS

2 JDMF

17 NDC API

1 VMF

13 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers

39 FDA Orange Book

4 Europe

16 Canada

2 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

2 DKSH

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

10 Actylis

11 BASF

1 Finar

5 Gangwal Chemicals

4 Kerry

2 Microlex e.U

1 Nanjing Bold Chemical

2 Nippon Fine Chemical

1 Pluviaendo

5 Roquette

7 Seppic

EXCIPIENTS BY APPLICATIONS

19 Topical

15 Solubilizers

13 Parenteral

9 Coating Systems & Additives

9 Thickeners and Stabilizers

8 Film Formers & Plasticizers

6 Emulsifying Agents

5 Direct Compression

5 Co-Processed Excipients

4 Surfactant & Foaming Agents

4 Fillers, Diluents & Binders

3 Granulation

3 Lubricants & Glidants

2 Taste Masking

2 Controlled & Modified Release

2 Rheology Modifiers

1 API Stability Enhancers

DIGITAL CONTENT

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 Regulatory FDF Prices

MARKET PLACE

22 APIs

1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 EDQM

1 USP

1 Others

Filters

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons